Glucosylceramide Synthase Inhibitors [MoA] - N0000020019
Pharmacologic Class Information
Pharmacologic Code | N0000020019 |
Pharmacologic Name | Glucosylceramide Synthase Inhibitors |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Glucosylceramide Synthase Inhibitors
The following table contains 6 products whose active ingredient are classified under the same pharmacologic class Glucosylceramide Synthase Inhibitors [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
10148-201 | Miglustat | Non-Proprietary Name: Miglustat | Capsule | Oral | Cotherix, Inc. | ACTIVE | |
42799-708 | Miglustat | Non-Proprietary Name: Miglustat | Capsule | Oral | Edenbridge Pharmaceuticals Llc. | ACTIVE | |
43975-310 | Miglustat | Non-Proprietary Name: Miglustat | Capsule | Oral | Ani Pharmaceuticals, Inc. | ACTIVE | |
51991-959 | Miglustat | Non-Proprietary Name: Miglustat | Capsule | Oral | Breckenridge Pharmaceutical, Inc. | ACTIVE | |
58468-0220 | Cerdelga | Non-Proprietary Name: Eliglustat | Capsule | Oral | Genzyme Corporation | ACTIVE | |
66215-201 | Zavesca | Non-Proprietary Name: Miglustat | Capsule | Oral | Actelion Pharmaceuticals Us, Inc. | ACTIVE |